Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ActivePure’s technology has been shown in peer-reviewed studies to reduce airborne SARS-CoV-2 by 99.98% within 60 seconds, eliminate MRSA in ICU environments, and significantly lower HAIs; devices are FDA-cleared as Class II Medical Devices for healthcare settings
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ActivePure Technologies.